Cover Image

Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects

Abstract Background and Objective Tinengotinib, a novel multi-target small molecule kinase inhibitor, is currently undergoing phase II clinical trial in the USA and China. The purpose of this open-label study was to investigate the absorption, metabolism, and excretion of [14C]tinengotinib following...

Full description

Saved in:
Bibliographic Details
Main Authors: Shumao Ni (Author), Sheng Ma (Author), Yingying Yu (Author), Zhenwen Yu (Author), Yujia Zhu (Author), Xiaofen Sun (Author), Lin Li (Author), Caixia Sun (Author), Hui Wang (Author), Peng Peng (Author), Zheming Gu (Author), Hua Zhang (Author), Frank Wu (Author), Liyan Miao (Author), Jean Fan (Author)
Format: Book
Published: Adis, Springer Healthcare, 2024-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items